Aim To investigate the respective influence of software tool and total metabolic tumor volume (TMTV0) calculation method on prognostic stratification of baseline 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography ([18F]FDG-PET) in newly diagnosed Hodgkin lymphoma (HL). Methods 59 patients with newly diagnosed HL were retrospectively included. [18F]FDG-PET was performed before any treatment. Four sets of TMTV0 were calculated with Beth Israel (BI) software: based on an absolute threshold selecting voxel with standardized uptake value (SUV)>2.5 (TMTV02.5), applying a per-lesion threshold of 41 % of the SUVmax (TMTV041) and using a per-patient adapted threshold based on SUVmax of the liver (>125 % and>140 % of SUVmax of the ...
International audience: PET performed after 2 cycles of chemotherapy (PET2) allows prediction of out...
We tested baseline PET/CT as a measure of total tumor burden in order to better identify high risk p...
BACKGROUND: This study was undertaken to evaluate the prognostic value of quantitative metabolic par...
To investigate the respective influence of software tool and total metabolic tumor volume (TMTV0) ca...
<div><p>Aim</p><p>To investigate the respective influence of software tool and total metabolic tumor...
Objective: Positron Emission Tomography (PET) with F-18-Fluoro-deoxy-glucose (FDG) emerged as a prog...
Background: Long-term survival from Hodgkin lymphoma (HL) is 80–90%, but the treatment has serious l...
We tested baseline positron emission tomography (PET)/computed tomography (CT) as a measure of total...
International audiencePURPOSE: The presence of a bulky tumour at staging in Hodgkin lymphoma (HL) is...
Background: Positron emission tomographic (PET) scanning utilizing [18F]fluorodeoxyglucose (FDG) is ...
Early assessment of response to chemotherapy with fluorine-18 fluorodeoxyglucose positron emission t...
Rationale: (18F)fluoro-2-deoxy-D-glucose (18F-FDG) positron emission tomography (PET)/computed tomog...
Background: F-18 -fluorodeoxyglucose (FDG) positron emission tomography (PET) plays an important rol...
PURPOSE: The authors evaluated the prognostic role of 18-fluoro-fluorodeoxyglucose positron emis...
: Rationale: Therapy response evaluation by 18F-fluorodeoxyglucose PET/CT (FDG PET) has become a pow...
International audience: PET performed after 2 cycles of chemotherapy (PET2) allows prediction of out...
We tested baseline PET/CT as a measure of total tumor burden in order to better identify high risk p...
BACKGROUND: This study was undertaken to evaluate the prognostic value of quantitative metabolic par...
To investigate the respective influence of software tool and total metabolic tumor volume (TMTV0) ca...
<div><p>Aim</p><p>To investigate the respective influence of software tool and total metabolic tumor...
Objective: Positron Emission Tomography (PET) with F-18-Fluoro-deoxy-glucose (FDG) emerged as a prog...
Background: Long-term survival from Hodgkin lymphoma (HL) is 80–90%, but the treatment has serious l...
We tested baseline positron emission tomography (PET)/computed tomography (CT) as a measure of total...
International audiencePURPOSE: The presence of a bulky tumour at staging in Hodgkin lymphoma (HL) is...
Background: Positron emission tomographic (PET) scanning utilizing [18F]fluorodeoxyglucose (FDG) is ...
Early assessment of response to chemotherapy with fluorine-18 fluorodeoxyglucose positron emission t...
Rationale: (18F)fluoro-2-deoxy-D-glucose (18F-FDG) positron emission tomography (PET)/computed tomog...
Background: F-18 -fluorodeoxyglucose (FDG) positron emission tomography (PET) plays an important rol...
PURPOSE: The authors evaluated the prognostic role of 18-fluoro-fluorodeoxyglucose positron emis...
: Rationale: Therapy response evaluation by 18F-fluorodeoxyglucose PET/CT (FDG PET) has become a pow...
International audience: PET performed after 2 cycles of chemotherapy (PET2) allows prediction of out...
We tested baseline PET/CT as a measure of total tumor burden in order to better identify high risk p...
BACKGROUND: This study was undertaken to evaluate the prognostic value of quantitative metabolic par...